Htydjtk

I'm looking for guidance on taking a large documnet such as this clinical study and extracting various pieces of information. For example, I'd like to locate "Exclusion criteria" and extract:

On page 8-9

Exclusion criteria:

The presence of any of the following will exclude a patient from study enrolment:

Suffering from another disease, which requires glucocorticoid treatment, e.g. asthma or

neurodermatitis

Synovectomy within 4 months prior to study start

Use of glucocorticoids (by any route) within 6 weeks prior to screening visit (Visit 0)

Use of biologicals: tumor necrosis factor α (TNFα) inhibitors within 3 months prior to

screening visit (Visit 0) or other compounds within 1 year prior to screening Visit 0

Clinically relevant abnormal laboratory values suggesting an unknown disease and

requiring further clinical evaluation

Pregnancy or nursing

Participation in another clinical study (use of an investigational product) within 30 days

preceding Visit 0

Re-entry of patients previously enrolled in this trial

Suspected inability or unwillingness to comply with study procedures

Alcohol or drug abuse

Requirement of nonpermitted concomitant medication

Known hypersensitivity to predniso(lo)ne

Any contraindication for low dose prednisone treatment

Significant renal impairment (serum creatinine > 150 µmol/L)

Significant hepatic impairment (investigator‟s opinion)

Any uncontrolled concomitant disease requiring further clinical evaluation

(e.g. uncontrolled diabetes, uncontrolled hypertension etc.)

On page 28

4.5 EXCLUSION CRITERIA

Patients presenting with any of the following will not be included in the study:

Suffering from another disease, which requires glucocorticoid treatment, e.g. asthma,

neurodermatitis

Synovectomy within 4 months prior to study start

Use of glucocorticoids (by any route) within 6 weeks prior to screening Visit 0

Use of biologicals: TNFα inhibitor within 3 months prior to screening Visit 0, other

compounds within 1 year prior to screening Visit 0

Clinically relevant abnormal laboratory values suggesting an unknown disease and

requiring further clinical evaluation

Pregnancy or nursing

Participation in another clinical study (use of an investigational product) within 30 days

preceding Visit 0

Re-entry of patients previously enrolled in this trial

Suspected inability or unwillingness to comply with study procedures

Alcohol or drug abuse

Requirement of nonpermitted concomitant medication

Known hypersensitivity to prednisone or predniso(lo)ne

Any contraindication for low dose prednisone treatment

Significant renal impairment (serum creatinine > 150 µmol/L)

Significant hepatic impairment (investigator‟s opinion)

Any uncontrolled concomitant disease requiring further clinical evaluation

(e.g. uncontrolled diabetes, uncontrolled hypertension etc.)

Any deviation or change from the protocol, including the inclusion/exclusion criteria, must

be approved in writing by the Sponsor and approved by the Institutional Review Board (IRB)

or Ethics Committee (EC). In accordance with local regulations, the Sponsor may be required

to notify local regulatory agencies.

A patient may not be enrolled nor randomized in this study more than once. A patient may

repeat the screening phase once, only if gastrointestinal bleeding can be excluded by a

gastroenterologist after the first Hemoccult/guaiac test was positive. No patients who have

previously been treated with the investigational product will be enrolled in this study.